Michael Sun Defends his thesis

This past Summer (2022), Michael Sun successfully defended his PhD thesis titled “Clot-Targeted Enzyme-Responsive Nanoparticles for Thrombolytic Therapy”. Congratulations Dr. Michael Sun!